Neurochem Completes Public Offering

Saint-Laurent, Quebec-based Neurochem Inc. completed, on September 23, 2003, a public offering in the US and in Canada resulting in gross proceeds of US$62 million, including the proceeds from the sale of shares following the exercise of the over-allotment option granted to the underwriters of the offering. The common shares of Neurochem were listed for quotation on NASDAQ in connection with the transaction, which represented the initial public offering of Neurochem’s shares in the US.

Neurochem was represented by David Skinner, director, legal, general counsel and secretary; and by Davies Ward Phillips & Vineberg LLP, with a team that included Richard Cherney, Neil Kravitz, Justin Vineberg, David Torralbo and Sébastien Roy in Montreal and Guy Lander, Scott Tayne and Charles Malone in New York.

The underwriting syndicate, led by UBS Securities LLC, was represented in Canada by Ogilvy Renault, with a team that included Renaud Coulombe, Natalie Brown and Adam Walsh; and in the US by Dewey Ballantine LLP, with a team that included Don Murray, Eric Blanchard and Margaret Lam in New York.